- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Whistler Medical Marijuana to begin shipping Live Cannabis Plants within Canada
Whistler Medical Marijuana Corp (WMMC) today announced that they are the first Licensed Producer of medicinal cannabis in Canada to offer access to their strain genetics through the shipment of live plants. The move builds upon WMMC’s existing organic product range of both dried marijuana and cannabis oils which are already available to eligible patients …
Whistler Medical Marijuana Corp (WMMC) today announced that they are the first Licensed Producer of medicinal cannabis in Canada to offer access to their strain genetics through the shipment of live plants. The move builds upon WMMC’s existing organic product range of both dried marijuana and cannabis oils which are already available to eligible patients as part of Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
Solidifying the company’s position as an industry leader, the expansion will allow patients to share in the substantial research and development invested into producing strong genetics at the companies Coast Mountain facility.
Hand cut from the same mother plants that produce WMMC’s own harvests, each plant shipped will represent three years of careful strain selection, dozens of test grow cycles, and detailed analysis by third party laboratories.
President Chris Pelz comments “True to the Whistler culture of pushing limits, we are thrilled to be the first Licensed Producer to offer some of our genetics to Canadians. We have invested significantly in our Plant Research Program here at WMMC and feel that it is important to share those R & D results to offer increased access to medicinal cannabis for ACMPR registered patients.”
Starting Monday 24th October, eligible ACMPR patients will be able to register with WMMC and purchase plants to produce their own medication. Plants will be shipped via express courier using Clone Shipper, www.cloneshipper.com
To find out more please go to www.wmmc.ca or call +1 604 962 3440.
About Whistler Medical Marijuana Corp.
Operating since 2014, WMMC was one of the first Licensed Producers to be issued a license to operate by Health Canada under the ACMPR (formerly the MMPR). Providing a full spectrum of cannabis products to patients WMMC are Canada’s only 100% organic producer as certified by the Fraser Valley Organic Producers Association. Continuously pioneering progress in medicinal cannabis development, WMMC were also the first producer in Canada to offer their patients access to both THCa and CBG Oils.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.